Motley Fool Asset Management LLC Biomarin Pharmaceutical Inc Transaction History

Motley Fool Asset Management LLC

$2.34 Billion
Q3 2025

A detailed history of Motley Fool Asset Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Motley Fool Asset Management LLC holds 32,019 shares of BMRN stock, worth $1.75 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

32,019

Previous 65,035 50.77%

Holding current value

$1.75 Million

Previous $3.57 Million 51.48%

% of portfolio

0.07%

Previous 0.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$52.62 - $61.93 $1.74 Million - $2.04 Million	-33,016 Reduced 50.77%	32,019 $1.73 Million
Q2 2025 Aug 01, 2025	BUY	$54.08 - $68.32 $2.79 Million - $3.53 Million	51,682 Added 387.04%	65,035 $3.57 Million
Q1 2025 May 12, 2025	BUY	$61.25 - $72.83 $2,511 - $2,986	41 Added 0.31%	13,353 $943,000
Q4 2024 Feb 12, 2025	SELL	$61.93 - $70.49 $8.39 Million - $9.55 Million	-135,486 Reduced 91.05%	13,312 $874,000
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $133,967 - $182,143	-1,941 Reduced 1.29%	148,798 $10.5 Million

Q2 2024 Aug 08, 2024	BUY	$74.43 - $92.22 $7.73 Million - $9.57 Million	103,824 Added 221.3%	150,739 $12.4 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $11.7 Million - $13.8 Million	-139,577 Reduced 74.84%	46,915 $4.1 Million
Q1 2024 May 08, 2024	BUY	$83.81 - $99.0 $11.9 Million - $14.1 Million	142,369 Added 322.66%	186,492 $16.3 Million
Q4 2023 Feb 02, 2024	SELL	$76.22 - $98.51 $94,360 - $121,955	-1,238 Reduced 2.73%	44,123 $4.25 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $3.57 Million - $3.96 Million	41,929 Added 1221.71%	45,361 $4.01 Million
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $297,485 - $344,229	3,432 New	3,432 $297,000
Q4 2022 Feb 09, 2023	SELL	$80.93 - $108.63 $21,932 - $29,438	-271 Reduced 7.45%	3,369 $348,000
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $6,901 - $8,142	-84 Reduced 2.26%	3,640 $309,000
Q2 2022 Aug 11, 2022	BUY	$71.48 - $86.85 $929 - $1,129	13 Added 0.35%	3,724 $322,000
Q1 2022 May 04, 2022	BUY	$74.28 - $92.69 $269,265 - $336,001	3,625 Added 4215.12%	3,711 $286,000
Q4 2021 Feb 10, 2022	BUY	$71.72 - $91.47 $6,167 - $7,866	86 New	86 $8,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $227,971 - $415,627	-3,172 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $9,546 - $14,906	120 Added 3.93%	3,172 $391,000
Q1 2020 May 13, 2020	BUY	$71.37 - $96.85 $217,821 - $295,586	3,052 New	3,052 $258,000
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $227,149 - $265,455	-2,827 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$84.2 - $98.62 $238,033 - $278,798	2,827 New	2,827 $251,000
Q4 2018 Feb 12, 2019	SELL	$80.14 - $106.07 $178,952 - $236,854	-2,233 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$93.92 - $105.72 $209,723 - $236,072	2,233 New	2,233 $217,000

Others Institutions Holding BMRN

# of Institutions

667

Shares Held

182M

Call Options Held

1.48M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Asset Management LLC with notifications on news.

Account

Motley Fool Asset Management LLC Biomarin Pharmaceutical Inc Transaction History